Joe Mcfadden

A personalized mRNA vaccine developed by Moderna and Merck, known as MSD in Europe, showed promising early results in a phase-three trial involving more than 1,000 high-risk melanoma patients who had undergone surgery. When combined with Keytruda, Intismeran significantly extended the time patients remained cancer-free and reduced the risk of the disease spreading compared with Keytruda alone. Cancer specialists described the findings as encouraging but stressed that the full results have not yet been published or independently peer-reviewed. Detailed findings are due to be presented at a medical conference in October, after which regulatory approval would still be required before the treatment could become available through the NHS.

A phase-three trial involving more than 1,000 patients with high-risk melanoma found that Moderna and Merck’s personalised mRNA vaccine, Intismeran, used alongside Keytruda, significantly extended the time patients remained cancer-free and reduced the risk of the disease spreading. Experts describe the findings as promising and potentially important for personalised cancer treatment, but caution that the full results have not yet been released or peer-reviewed. The treatment would still require regulatory and NHS approval before becoming available in the UK.

A phase three trial involving more than 1,000 patients with high-risk melanoma found that Moderna and Merck/MSD’s personalised mRNA vaccine, Intismeran, combined with Keytruda, extended the time patients remained cancer-free and reduced the risk of the cancer spreading compared with Keytruda alone. Experts described the results as promising and potentially important, but cautioned that the full findings have not yet been released or peer-reviewed. The treatment would still require regulatory approval before possible NHS availability, with detailed results expected at a medical conference in October.

Obesity among adults in England rose from 15% in 1993 to 30% in 2024, leaving about 14 million adults affected and roughly seven million more than if rates had remained unchanged. The increase is linked to more sedentary work, cheaper and more accessible high-fat, high-salt and high-sugar food, the expansion of takeaways and delivery services, and deprivation. Fourteen national obesity strategies have been introduced since 1992, including advertising restrictions and the 2018 sugar levy, but campaigners say progress has been too slow and further measures have been delayed. Weight-loss drugs such as Wegovy and Mounjaro are expanding, although NHS access is limited and health officials warn that lifelong medication cannot be the only solution. Young adults have experienced the fastest rise, prompting calls for broader action on food marketing, pricing, urban planning and access to healthier choices.

Obesity among adults in England rose from 15% in 1993 to 30% in 2024, leaving about 14 million adults affected and roughly seven million more than if rates had remained unchanged. The increase is linked to more sedentary employment, cheaper and more accessible high-fat, high-salt and high-sugar food, the growth of takeaways and delivery services, deprivation, and cost-of-living pressures. Successive governments have introduced 14 obesity strategies, advertising restrictions and a levy on sugary drinks, but campaigners say implementation has been too slow. Weight-loss drugs such as Wegovy and Mounjaro are expanding, although NHS access is limited, and health officials warn that medication cannot be the sole response to a wider societal and food-environment problem.

Research discussed by cognitive scientist Edgar Dubourg and psychologist Valerie van Mulukom suggests that people’s book choices may reflect underlying motivations, emotional preferences and existential anxieties. Readers drawn to crime, thrillers and horror may be engaged with themes of threat and danger; romance readers may be focused on relationships, social status and belonging; science fiction and fantasy readers may be concerned about global risks such as climate change and war; and readers of biographies, history and documentaries may be seeking facts and explanations. The article emphasizes that both fiction and nonfiction satisfy a general human appetite for narratives, while cautioning implicitly that genre preferences offer suggestive psychological clues rather than definitive diagnoses.